Study challenges giving nevirapine to pregnant AIDS patients

02/10/2004 | Washington Post (tiered subscription model), The

Giving pregnant women suffering from AIDS the drug nevirapine to avoid infecting their children may limit a mother's own treatment later, according to new research. Scientists said giving the women a single dose of the drug could lead to resistance to nevirapine later, complicating plans to try to prevent the transmission of AIDS from mother to child.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA